-
Tychan to Begin First Clinical Trials for First Novel Monoclonal Antibody Against COVID-19
Tychan, a Singapore-based clinical-stage biotechnology company, is initiating Phase 1 clinical trials to evaluate TY027, the first novel monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus that causes COVID-19.
-
A boost for cancer immunotherapy
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.
-
Half of U.S. deaths related to air pollution are linked to out-of-state emissions
Study tracks pollution from state to state in the 48 contiguous United States.
-
Your Cervical Mucus Is Beautiful
The protective substance is an important barrier between a woman’s body and the environment. Here’s how researchers are using it to understand health.
-
The MIT Superfund Research Program: Studies on Cleaning Up Genes and the Environment
In the United States, there are thousands of industrial sites contaminated by the irresponsible disposal of chemical waste. The higher than expected frequency of cancer cases near these sites has caused alarm, since many of the chemical contaminants found at these sites have been linked to the development of long-term health problems, including cancer. As leaders of the Massachusetts Institute of Technology Superfund Research Program, Dr Jennifer Kay (Research Scientist and Research Translation Director) and Professor Bevin Page Engelward (Program Director) are using their expertise to investigate the genetic factors that influence susceptibility to adverse health outcomes following exposure to environmental chemicals.
-
Thank you for your patients
An unusual synergy between cancer researchers, clinical centers, and industry leads to promising clinical trials for a new combination therapy for prostate cancer.
-
Newly discovered enzyme “square dance” helps generate DNA building blocks
MIT biochemists can trap and visualize an enzyme as it becomes active — an important development that may aid in future drug development.
-
A stopgap measure to treat respiratory distress
Repurposing a drug used for blood clots may help Covid-19 patients in danger of respiratory failure, researchers suggest.
-
CRISPR-based diagnostic chips perform thousands of tests simultaneously to detect viruses
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
-
3 Questions: Michael Yaffe on treating Covid-19 patients with acute respiratory distress
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
